- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT01824875
Temozolomida com ou sem capecitabina no tratamento de pacientes com tumores neuroendócrinos pancreáticos avançados
Um Estudo Randomizado de Fase II de Temozolomida ou Temozolomida e Capecitabina em Pacientes com Tumores Neuroendócrinos Pancreáticos Avançados
This randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors. Drugs used in chemotherapy, such as temozolomide and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether temozolomide is more effective with or without capecitabine in treating patients with advanced pancreatic neuroendocrine tumors.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
PRIMARY OBJECTIVES:
I. To evaluate progression-free survival (PFS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
SECONDARY OBJECTIVES:
I. To evaluate response rates (RR) associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
II. To evaluate overall survival (OS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
III. To evaluate the toxicity associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
IV. To evaluate the usefulness of methyl guanine methyltransferase (MGMT) status (by immunohistochemistry [IHC] and promoter methylation) for predicting response in pancreatic neuroendocrine tumor patients treated with either temozolomide or temozolomide and capecitabine.
V. To bank radiology images for evaluation of quality, reproducibility, and compliance with computed tomography (CT) methodology.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM A: Patients receive temozolomide orally (PO) once daily (QD) on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
ARM B: Patients receive capecitabine PO twice daily (BID) on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for 2 years, and then every 6 months for 3 years.
Tipo de estudo
Inscrição (Real)
Estágio
- Fase 2
Contactos e Locais
Locais de estudo
-
-
California
-
Anaheim, California, Estados Unidos, 92807
- Kaiser Anaheim Medical Center
-
Antioch, California, Estados Unidos, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Baldwin Park, California, Estados Unidos, 91706
- Kaiser Permanente Medical Group - Baldwin Park
-
Bellflower, California, Estados Unidos, 90706
- Kaiser Foundation Hospital
-
Berkeley, California, Estados Unidos, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Burlingame, California, Estados Unidos, 94010
- Mills - Peninsula Hospitals
-
Fontana, California, Estados Unidos, 92335
- Kaiser Permanente Hospital
-
Fremont, California, Estados Unidos, 94538
- Kaiser Permanente, Fremont
-
Fresno, California, Estados Unidos, 93720
- Kaiser Permanente
-
Harbor City, California, Estados Unidos, 90710
- Kaiser Permanente - Harbor City
-
Hayward, California, Estados Unidos, 94545
- Kaiser Permanente, Hayward
-
Irvine, California, Estados Unidos, 92618
- Southern California Permanente Medical Group
-
Los Angeles, California, Estados Unidos, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, Estados Unidos, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, Estados Unidos, 90033
- University of Southern California/Norris Cancer Center
-
Los Angeles, California, Estados Unidos, 90034
- Kaiser Permanente-West Los Angeles
-
Modesto, California, Estados Unidos, 95356
- Kaiser Permanente-Modesto
-
Novato, California, Estados Unidos, 94945
- Sutter Cancer Research Consortium
-
Oakland, California, Estados Unidos, 94611
- Kaiser Permanente-Oakland
-
Orange, California, Estados Unidos, 92868
- University of California Medical Center At Irvine-Orange Campus
-
Panorama City, California, Estados Unidos, 91402
- Kaiser Permanente - Panorama City
-
Redwood City, California, Estados Unidos, 94063
- Kaiser Permanente-Redwood City
-
Richmond, California, Estados Unidos, 94801
- Kaiser Permanente-Richmond
-
Riverside, California, Estados Unidos, 92505
- Kaiser Permanente Medical Center
-
Roseville, California, Estados Unidos, 95661
- Kaiser Permanente-Roseville
-
Sacramento, California, Estados Unidos, 95823
- Kaiser Permanente-South Sacramento
-
Sacramento, California, Estados Unidos, 95825
- Kaiser Permanente - Sacramento
-
San Diego, California, Estados Unidos, 92120
- Kaiser Permanente at San Diego
-
San Diego, California, Estados Unidos, 92120
- Kaiser Permanente
-
San Francisco, California, Estados Unidos, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, Estados Unidos, 94118
- California Pacific Medical Center
-
San Francisco, California, Estados Unidos, 94115
- UCSF-Mount Zion
-
San Jose, California, Estados Unidos, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Marcos, California, Estados Unidos, 92069
- Kaiser Permanente Health Care
-
San Rafael, California, Estados Unidos, 94903
- Kaiser Permanente-San Rafael
-
Santa Clara, California, Estados Unidos, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, Estados Unidos, 95403
- Kaiser Permanente-Santa Rosa
-
Santa Rosa, California, Estados Unidos, 95403
- Sutter Pacific Medical Foundation
-
South San Francisco, California, Estados Unidos, 94080
- Kaiser Permanente-South San Francisco
-
Stanford, California, Estados Unidos, 94305
- Stanford University Hospitals and Clinics
-
Stockton, California, Estados Unidos, 95210
- Kaiser Permanente-Stockton
-
Vacaville, California, Estados Unidos, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Estados Unidos, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, Estados Unidos, 94589
- Sutter Solano Medical Center
-
Walnut Creek, California, Estados Unidos, 94596
- Kaiser Permanente-Walnut Creek
-
Woodland Hills, California, Estados Unidos, 91367
- Kaiser Permanente
-
-
Connecticut
-
Hartford, Connecticut, Estados Unidos, 06105
- Saint Francis Hospital and Medical Center
-
Middletown, Connecticut, Estados Unidos, 06457
- Middlesex Hospital
-
-
Delaware
-
Lewes, Delaware, Estados Unidos, 19958
- Beebe Medical Center
-
Newark, Delaware, Estados Unidos, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Estados Unidos, 19713
- Delaware Clinical and Laboratory Physicians PA
-
Newark, Delaware, Estados Unidos, 19713
- Medical Oncology Hematology Consultants PA
-
Newark, Delaware, Estados Unidos, 19718
- Christiana Care Health System-Christiana Hospital
-
Newark, Delaware, Estados Unidos, 19713
- Christiana Gynecologic Oncology LLC
-
Newark, Delaware, Estados Unidos, 19713
- Regional Hematology and Oncology PA
-
Rehoboth Beach, Delaware, Estados Unidos, 19971
- Beebe Health Campus
-
Seaford, Delaware, Estados Unidos, 19973
- Nanticoke Memorial Hospital
-
Wilmington, Delaware, Estados Unidos, 19801
- Christiana Care Health System-Wilmington Hospital
-
-
Florida
-
Jacksonville, Florida, Estados Unidos, 32207
- Edna Williams Cancer Center at the Baptist Cancer Institute
-
Miami, Florida, Estados Unidos, 33136
- University of Miami Miller School of Medicine-Sylvester Cancer Center
-
Orlando, Florida, Estados Unidos, 32803
- Florida Hospital
-
Tampa, Florida, Estados Unidos, 33612
- H. Lee Moffitt Cancer Center and Research Institute
-
-
Hawaii
-
Honolulu, Hawaii, Estados Unidos, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Estados Unidos, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Estados Unidos, 96819
- Kaiser Permanente Moanalua Medical Center
-
Honolulu, Hawaii, Estados Unidos, 96813
- University of Hawaii
-
Honolulu, Hawaii, Estados Unidos, 96813
- Oncare Hawaii Inc-POB II
-
Honolulu, Hawaii, Estados Unidos, 96817-3169
- OnCare Hawaii-Liliha
-
Honolulu, Hawaii, Estados Unidos, 96817
- Oncare Hawaii Inc-Kuakini
-
Kailua, Hawaii, Estados Unidos, 96734
- Castle Medical Center
-
Lihue, Hawaii, Estados Unidos, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, Estados Unidos, 96701
- Pali Momi Medical Center
-
‘Aiea, Hawaii, Estados Unidos, 96701
- Oncare Hawaii Inc-Pali Momi
-
-
Idaho
-
Boise, Idaho, Estados Unidos, 83706
- Saint Alphonsus Regional Medical Center
-
-
Illinois
-
Bloomington, Illinois, Estados Unidos, 61701
- Saint Joseph Medical Center
-
Bloomington, Illinois, Estados Unidos, 61701
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Estados Unidos, 61520
- Illinois CancerCare-Canton
-
Carbondale, Illinois, Estados Unidos, 62902
- Memorial Hospital of Carbondale
-
Carthage, Illinois, Estados Unidos, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Estados Unidos, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Estados Unidos, 60611
- Northwestern University
-
Chicago, Illinois, Estados Unidos, 60612
- University of Illinois
-
Decatur, Illinois, Estados Unidos, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Estados Unidos, 62526
- Cancer Care Center of Decatur
-
Effingham, Illinois, Estados Unidos, 62401
- Crossroads Cancer Center
-
Eureka, Illinois, Estados Unidos, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Estados Unidos, 61401
- Illinois CancerCare Galesburg
-
Galesburg, Illinois, Estados Unidos, 61401
- Illinois CancerCare-Galesburg Cottage Plaza Office
-
Highland Park, Illinois, Estados Unidos, 60035
- Hematology Oncology Associates of Illinois-Highland Park
-
Hinsdale, Illinois, Estados Unidos, 60521
- Hinsdale Hematology Oncology Associates Incorporated
-
Kankakee, Illinois, Estados Unidos, 60901
- Presence Saint Mary's Hospital
-
Kewanee, Illinois, Estados Unidos, 61443
- Illinois CancerCare-Kewanee Clinic
-
Libertyville, Illinois, Estados Unidos, 60048
- North Shore Hematology Oncology
-
Macomb, Illinois, Estados Unidos, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, Estados Unidos, 60153
- Loyola University Medical Center
-
Moline, Illinois, Estados Unidos, 61265
- Garneau, Stewart C MD (UIA Investigator)
-
Moline, Illinois, Estados Unidos, 61265
- Porubcin, Michael MD (UIA Investigator)
-
Moline, Illinois, Estados Unidos, 61265
- Spector, David MD (UIA Investigator)
-
Moline, Illinois, Estados Unidos, 61265
- Trinity Medical Center
-
Monmouth, Illinois, Estados Unidos, 61462
- Illinois CancerCare-Monmouth
-
Mount Vernon, Illinois, Estados Unidos, 62864
- Good Samaritan Regional Health Center
-
Niles, Illinois, Estados Unidos, 60714
- Illinois Cancer Specialists-Niles
-
Normal, Illinois, Estados Unidos, 61761
- Community Cancer Center Foundation
-
Ottawa, Illinois, Estados Unidos, 61350
- Illinois CancerCare-Ottawa Clinic
-
Ottawa, Illinois, Estados Unidos, 61350
- Ottawa Regional Hospital and Healthcare Center
-
Pekin, Illinois, Estados Unidos, 61554
- Pekin Cancer Treatment Center
-
Pekin, Illinois, Estados Unidos, 61603
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Estados Unidos, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, Estados Unidos, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, Estados Unidos, 61614
- Proctor Hospital
-
Peoria, Illinois, Estados Unidos, 61603
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Estados Unidos, 61615
- Illinois Oncology Research Association CCOP
-
Peru, Illinois, Estados Unidos, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Estados Unidos, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, Estados Unidos, 61107
- SwedishAmerican Regional Cancer Center/ACT
-
Skokie, Illinois, Estados Unidos, 60076
- Hematology Oncology Associates of Illinois - Skokie
-
Springfield, Illinois, Estados Unidos, 62781-0001
- Memorial Medical Center
-
-
Indiana
-
Indianapolis, Indiana, Estados Unidos, 46237
- Franciscan Saint Francis Health-Indianapolis
-
Richmond, Indiana, Estados Unidos, 47374
- Reid Hospital and Health Care Services
-
-
Iowa
-
Ames, Iowa, Estados Unidos, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Estados Unidos, 50010
- McFarland Clinic PC-William R Bliss Cancer Center
-
Bettendorf, Iowa, Estados Unidos, 52722
- Constantinou, Costas L MD (UIA Investigator)
-
Boone, Iowa, Estados Unidos, 50036
- McFarland Clinic PC-Boone
-
Clive, Iowa, Estados Unidos, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Estados Unidos, 50325
- Medical Oncology and Hematology Associates-West Des Moines
-
Des Moines, Iowa, Estados Unidos, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Estados Unidos, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Estados Unidos, 50309
- Medical Oncology and Hematology Associates-Des Moines
-
Des Moines, Iowa, Estados Unidos, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Estados Unidos, 50314
- Medical Oncology and Hematology Associates-Laurel
-
Des Moines, Iowa, Estados Unidos, 50309
- Iowa Oncology Research Association CCOP
-
Jefferson, Iowa, Estados Unidos, 50129
- McFarland Clinic PC-Jefferson
-
Marshalltown, Iowa, Estados Unidos, 50158
- McFarland Clinic PC-Marshalltown
-
Sioux City, Iowa, Estados Unidos, 51104
- Saint Luke's Regional Medical Center
-
Sioux City, Iowa, Estados Unidos, 51101
- Siouxland Hematology Oncology Associates
-
Sioux City, Iowa, Estados Unidos, 51104
- Mercy Medical Center-Sioux City
-
West Des Moines, Iowa, Estados Unidos, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Estados Unidos, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Chanute, Kansas, Estados Unidos, 66720
- Cancer Center of Kansas - Chanute
-
Dodge City, Kansas, Estados Unidos, 67801
- Cancer Center of Kansas - Dodge City
-
El Dorado, Kansas, Estados Unidos, 67042
- Cancer Center of Kansas - El Dorado
-
Fort Scott, Kansas, Estados Unidos, 66701
- Cancer Center of Kansas - Fort Scott
-
Independence, Kansas, Estados Unidos, 67301
- Cancer Center of Kansas-Independence
-
Kingman, Kansas, Estados Unidos, 67068
- Cancer Center of Kansas-Kingman
-
Lawrence, Kansas, Estados Unidos, 66044
- Lawrence Memorial Hospital
-
Liberal, Kansas, Estados Unidos, 67901
- Cancer Center of Kansas-Liberal
-
Manhattan, Kansas, Estados Unidos, 66502
- Cancer Center of Kansas-Manhattan
-
McPherson, Kansas, Estados Unidos, 67460
- Cancer Center of Kansas - McPherson
-
Newton, Kansas, Estados Unidos, 67114
- Cancer Center of Kansas - Newton
-
Parsons, Kansas, Estados Unidos, 67357
- Cancer Center of Kansas - Parsons
-
Pratt, Kansas, Estados Unidos, 67124
- Cancer Center of Kansas - Pratt
-
Salina, Kansas, Estados Unidos, 67401
- Cancer Center of Kansas - Salina
-
Wellington, Kansas, Estados Unidos, 67152
- Cancer Center of Kansas - Wellington
-
Wichita, Kansas, Estados Unidos, 67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita, Kansas, Estados Unidos, 67208
- Associates In Womens Health
-
Wichita, Kansas, Estados Unidos, 67214
- Cancer Center of Kansas - Main Office
-
Wichita, Kansas, Estados Unidos, 67214
- Via Christi Regional Medical Center
-
Wichita, Kansas, Estados Unidos, 67214
- Wichita CCOP
-
Winfield, Kansas, Estados Unidos, 67156
- Cancer Center of Kansas - Winfield
-
-
Kentucky
-
Crestview Hills, Kentucky, Estados Unidos, 41017
- Oncology Hematology Care Incorporated
-
-
Louisiana
-
Baton Rouge, Louisiana, Estados Unidos, 70809
- Ochsner Health Center-Summa
-
New Orleans, Louisiana, Estados Unidos, 70121
- Ochsner Medical Center Jefferson
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02118
- Boston Medical Center
-
Burlington, Massachusetts, Estados Unidos, 01805
- Lahey Hospital and Medical Center
-
-
Michigan
-
Adrian, Michigan, Estados Unidos, 49221
- Bixby Medical Center
-
Adrian, Michigan, Estados Unidos, 49221
- Hickman Cancer Center
-
Ann Arbor, Michigan, Estados Unidos, 48106-0995
- Saint Joseph Mercy Hospital
-
Ann Arbor, Michigan, Estados Unidos, 48106
- Michigan Cancer Research Consortium Community Clinical Oncology Program
-
Ann Arbor, Michigan, Estados Unidos, 48109
- University of Michigan University Hospital
-
Dearborn, Michigan, Estados Unidos, 48124
- Oakwood Hospital
-
Detroit, Michigan, Estados Unidos, 48236
- Saint John Hospital and Medical Center
-
Flint, Michigan, Estados Unidos, 48502
- Hurley Medical Center
-
Flint, Michigan, Estados Unidos, 48503
- Genesys Hurley Cancer Institute
-
Jackson, Michigan, Estados Unidos, 49201
- Allegiance Health
-
Kalamazoo, Michigan, Estados Unidos, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Estados Unidos, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Estados Unidos, 49001
- Borgess Medical Center
-
Lansing, Michigan, Estados Unidos, 48912
- Sparrow Hospital
-
Livonia, Michigan, Estados Unidos, 48154
- Saint Mary Mercy Hospital
-
Monroe, Michigan, Estados Unidos, 48162
- Mercy Memorial Hospital
-
Monroe, Michigan, Estados Unidos, 48162
- Community Cancer Center of Monroe
-
Pontiac, Michigan, Estados Unidos, 48341-2985
- Saint Joseph Mercy Oakland
-
Port Huron, Michigan, Estados Unidos, 48060
- Saint Joseph Mercy Port Huron
-
Saginaw, Michigan, Estados Unidos, 48601
- Saint Mary's of Michigan
-
Warren, Michigan, Estados Unidos, 48093
- Saint John Macomb-Oakland Hospital
-
-
Minnesota
-
Burnsville, Minnesota, Estados Unidos, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, Estados Unidos, 55433
- Mercy Hospital
-
Edina, Minnesota, Estados Unidos, 55435
- Fairview-Southdale Hospital
-
Fridley, Minnesota, Estados Unidos, 55432
- Unity Hospital
-
Hutchinson, Minnesota, Estados Unidos, 55350
- Hutchinson Area Health Care
-
Maplewood, Minnesota, Estados Unidos, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Estados Unidos, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Estados Unidos, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Estados Unidos, 55407
- Abbott-Northwestern Hospital
-
New Ulm, Minnesota, Estados Unidos, 56073
- New Ulm Medical Center
-
Robbinsdale, Minnesota, Estados Unidos, 55422
- North Memorial Medical Health Center
-
Saint Louis Park, Minnesota, Estados Unidos, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park, Minnesota, Estados Unidos, 55416
- Metro-Minnesota CCOP
-
Saint Paul, Minnesota, Estados Unidos, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Estados Unidos, 55102
- United Hospital
-
Shakopee, Minnesota, Estados Unidos, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Estados Unidos, 55082
- Lakeview Hospital
-
Waconia, Minnesota, Estados Unidos, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Estados Unidos, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Estados Unidos, 55125
- Minnesota Oncology and Hematology PA-Woodbury
-
-
Missouri
-
Bolivar, Missouri, Estados Unidos, 65613
- Central Care Cancer Center-Carrie J Babb Cancer Center
-
Branson, Missouri, Estados Unidos, 65616
- CoxHealth Cancer Center
-
Cape Girardeau, Missouri, Estados Unidos, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Estados Unidos, 63703
- Southeast Cancer Center
-
Jefferson City, Missouri, Estados Unidos, 65109
- Capital Region Medical Center-Goldschmidt Cancer Center
-
Rolla, Missouri, Estados Unidos, 65401
- Phelps County Regional Medical Center
-
Rolla, Missouri, Estados Unidos, 65401
- Saint John's Clinic-Rolla-Cancer and Hematology
-
Springfield, Missouri, Estados Unidos, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Estados Unidos, 65804
- Mercy Hospital Springfield
-
Springfield, Missouri, Estados Unidos, 65802
- Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
-
St Louis, Missouri, Estados Unidos, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Estados Unidos, 63109
- Saint Louis Cancer and Breast Institute-South City
-
St Louis, Missouri, Estados Unidos, 63141
- Saint John's Mercy Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Estados Unidos, 68114
- Nebraska Methodist Hospital
-
-
Nevada
-
Las Vegas, Nevada, Estados Unidos, 89106
- Nevada Cancer Research Foundation CCOP
-
-
New Jersey
-
Camden, New Jersey, Estados Unidos, 08103
- Cooper Hospital University Medical Center
-
Mount Holly, New Jersey, Estados Unidos, 08060
- Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County
-
Voorhees Township, New Jersey, Estados Unidos, 08043
- Virtua West Jersey Hospital Voorhees
-
-
New York
-
Albany, New York, Estados Unidos, 12208
- New York Oncology Hematology PC -Albany Medical Center
-
Albany, New York, Estados Unidos, 12206
- New York Oncology Hematology PC - Albany
-
Amsterdam, New York, Estados Unidos, 12010
- New York Oncology Hematology PC - Amsterdam
-
Hudson, New York, Estados Unidos, 12534
- New York Oncology Hematology PC-Hudson
-
Latham, New York, Estados Unidos, 12110
- New York Oncology Hematology PC - Latham
-
Rexford, New York, Estados Unidos, 12148
- New York Oncology Hematology PC - Rexford
-
Rochester, New York, Estados Unidos, 14642
- University of Rochester
-
The Bronx, New York, Estados Unidos, 10467-2490
- Montefiore Medical Center
-
The Bronx, New York, Estados Unidos, 10461
- Montefiore Medical Center-Weiler Division
-
Troy, New York, Estados Unidos, 12180
- New York Oncology Hematology PC - Troy
-
-
North Carolina
-
Kinston, North Carolina, Estados Unidos, 28501
- Kinston Medical Specialists PA
-
Statesville, North Carolina, Estados Unidos, 28677
- Iredell Memorial Hospital
-
-
Ohio
-
Akron, Ohio, Estados Unidos, 44307
- Akron General Medical Center
-
Beachwood, Ohio, Estados Unidos, 44122
- Cleveland Clinic Cancer Center Beachwood
-
Belpre, Ohio, Estados Unidos, 45714
- Strecker Cancer Center-Belpre
-
Bowling Green, Ohio, Estados Unidos, 43402
- Toledo Clinic Cancer Centers-Bowling Green
-
Chillicothe, Ohio, Estados Unidos, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Estados Unidos, 45267
- University of Cincinnati
-
Cincinnati, Ohio, Estados Unidos, 45230
- Oncology Hematology Care Inc - Anderson
-
Cincinnati, Ohio, Estados Unidos, 45236
- Oncology Hematology Care Inc - Kenwood
-
Cincinnati, Ohio, Estados Unidos, 45219
- Oncology and Hematology Care Incorporated
-
Cincinnati, Ohio, Estados Unidos, 45242
- Oncology and Hematology Care Inc - Blue Ash
-
Cincinnati, Ohio, Estados Unidos, 45248
- Oncology Hematology Care Inc - Western Hills
-
Cleveland, Ohio, Estados Unidos, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Estados Unidos, 44195
- Cleveland Clinic Foundation
-
Columbus, Ohio, Estados Unidos, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Estados Unidos, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Estados Unidos, 43210
- Ohio State University Medical Center
-
Columbus, Ohio, Estados Unidos, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, Estados Unidos, 43228
- Doctors Hospital
-
Columbus, Ohio, Estados Unidos, 43215
- Grant Medical Center
-
Columbus, Ohio, Estados Unidos, 43222
- Mount Carmel Health Center West
-
Columbus, Ohio, Estados Unidos, 43215
- Columbus CCOP
-
Dayton, Ohio, Estados Unidos, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, Estados Unidos, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Estados Unidos, 45415
- Samaritan North Health Center
-
Dayton, Ohio, Estados Unidos, 45405
- Grandview Hospital
-
Dayton, Ohio, Estados Unidos, 45420
- Dayton CCOP
-
Delaware, Ohio, Estados Unidos, 43015
- Delaware Health Center-Grady Cancer Center
-
Delaware, Ohio, Estados Unidos, 43015
- Delaware Radiation Oncology
-
Delaware, Ohio, Estados Unidos, 43015
- Grady Memorial Hospital
-
Elyria, Ohio, Estados Unidos, 44035
- Mercy Cancer Center-Elyria
-
Elyria, Ohio, Estados Unidos, 44035
- Hematology Oncology Center Incorporated
-
Fairfield, Ohio, Estados Unidos, 45014
- Oncology Hematology Care Inc
-
Findlay, Ohio, Estados Unidos, 45840
- Blanchard Valley Hospital
-
Franklin, Ohio, Estados Unidos, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville, Ohio, Estados Unidos, 45331
- Wayne Hospital
-
Independence, Ohio, Estados Unidos, 44131
- Cleveland Clinic Cancer Center Independence
-
Kettering, Ohio, Estados Unidos, 45429
- Kettering Medical Center
-
Lancaster, Ohio, Estados Unidos, 43130
- Fairfield Medical Center
-
Lancaster, Ohio, Estados Unidos, 43130
- Lancaster Radiation Oncology
-
Lima, Ohio, Estados Unidos, 45801
- Saint Rita's Medical Center
-
Lima, Ohio, Estados Unidos, 45804
- Lima Memorial Hospital
-
Marietta, Ohio, Estados Unidos, 45750
- Marietta Memorial Hospital
-
Maumee, Ohio, Estados Unidos, 43537
- Toledo Clinic Cancer Centers-Maumee
-
Maumee, Ohio, Estados Unidos, 43537
- Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
-
Mayfield Heights, Ohio, Estados Unidos, 44124
- Hillcrest Hospital Cancer Center
-
Mount Vernon, Ohio, Estados Unidos, 43050
- Knox Community Hospital
-
Newark, Ohio, Estados Unidos, 43055
- Licking Memorial Hospital
-
Newark, Ohio, Estados Unidos, 43055
- Newark Radiation Oncology
-
Oregon, Ohio, Estados Unidos, 43616
- Saint Charles Hospital
-
Oregon, Ohio, Estados Unidos, 43616
- Toledo Clinic Cancer Centers-Oregon
-
Portsmouth, Ohio, Estados Unidos, 45662
- Southern Ohio Medical Center
-
Sandusky, Ohio, Estados Unidos, 44870
- North Coast Cancer Care
-
Springfield, Ohio, Estados Unidos, 45505
- Springfield Regional Medical Center
-
Strongsville, Ohio, Estados Unidos, 44136
- Cleveland Clinic Cancer Center-Strongsville
-
Sylvania, Ohio, Estados Unidos, 43560
- Flower Hospital
-
Tiffin, Ohio, Estados Unidos, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, Estados Unidos, 43608
- Saint Vincent Mercy Medical Center
-
Toledo, Ohio, Estados Unidos, 43623
- Toledo Clinic Cancer Centers-Toledo
-
Toledo, Ohio, Estados Unidos, 43614
- University of Toledo
-
Toledo, Ohio, Estados Unidos, 43617
- Toledo Community Hospital Oncology Program CCOP
-
Toledo, Ohio, Estados Unidos, 43606
- The Toledo Hospital/Toledo Children's Hospital
-
Toledo, Ohio, Estados Unidos, 43623
- Mercy Saint Anne Hospital
-
Troy, Ohio, Estados Unidos, 45373
- Upper Valley Medical Center
-
Wauseon, Ohio, Estados Unidos, 43567
- Fulton County Health Center
-
Westerville, Ohio, Estados Unidos, 43081
- Saint Ann's Hospital
-
Xenia, Ohio, Estados Unidos, 45385
- Greene Memorial Hospital
-
Zanesville, Ohio, Estados Unidos, 43701
- Genesis HealthCare System
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Estados Unidos, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Estados Unidos, 74146
- Tulsa Cancer Institute
-
-
Pennsylvania
-
Danville, Pennsylvania, Estados Unidos, 17822-2001
- Geisinger Medical Center
-
Hazleton, Pennsylvania, Estados Unidos, 18201
- Geisinger Medical Center-Cancer Center Hazleton
-
Hershey, Pennsylvania, Estados Unidos, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Lewisburg, Pennsylvania, Estados Unidos, 17837
- Geisinger Medical Oncology at Evangelical Community Hospital
-
Philadelphia, Pennsylvania, Estados Unidos, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Estados Unidos, 19107
- Thomas Jefferson University Hospital
-
Pottsville, Pennsylvania, Estados Unidos, 17901
- Geisinger Medical Oncology-Pottsville
-
State College, Pennsylvania, Estados Unidos, 16801
- Geisinger Medical Group
-
West Reading, Pennsylvania, Estados Unidos, 19611
- Reading Hospital
-
Wilkes-Barre, Pennsylvania, Estados Unidos, 18711
- Geisinger Wyoming Valley
-
-
South Carolina
-
Greenville, South Carolina, Estados Unidos, 29605
- Greenville Health System Cancer Institute-Butternut
-
Greenville, South Carolina, Estados Unidos, 29615
- Greenville Health System Cancer Institute/Greenville CCOP
-
Greer, South Carolina, Estados Unidos, 29650
- Greenville Health System Cancer Institute-Greer
-
-
Tennessee
-
Nashville, Tennessee, Estados Unidos, 37232-6838
- Vanderbilt Cancer Center
-
-
Virginia
-
Fredericksburg, Virginia, Estados Unidos, 22401
- Fredericksburg Oncology Inc
-
-
Wisconsin
-
La Crosse, Wisconsin, Estados Unidos, 54601
- Gundersen Lutheran
-
Madison, Wisconsin, Estados Unidos, 53792
- University of Wisconsin Hospital and Clinics
-
Milwaukee, Wisconsin, Estados Unidos, 53226
- Froedtert and the Medical College of Wisconsin
-
New Richmond, Wisconsin, Estados Unidos, 54017
- Cancer Center of Western Wisconsin
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
-
Patient must have histologically or pathologically confirmed locally unresectable or metastatic low or intermediate grade pancreatic neuroendocrine tumor
-
Patient must have measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria; baseline measurements and evaluations of all sites of disease must be obtained <= 4 weeks prior to randomization and must be acquired by multiphasic CT or contrast magnetic resonance imaging (MRI)
-
Date of last documented disease progression must be within 12 months from date of randomization
-
Prior everolimus and/or sunitinib therapy is allowed, so long as it was discontinued >= 4 weeks prior to randomization
-
Concurrent somatostatin analogues are allowed provided that patients
- Have been on a stable dose for 8 weeks and
- Have documented disease progression on that dose
-
Chemoembolization is allowed if ≥ 4 weeks from study entry. There are 2 possible scenarios:
- If patient has hepatic disease only: they need to have progressed in the liver since chemoembolization and have measurable disease by RECIST 1.1 in order to be eligible.
- If patient has hepatic and extrahepatic disease: they will need to have progressed inside OR outside the liver and have measureable disease by RECIST 1.1 in order to be eligible.
-
Leukocytes >= 3,000/mm^3
-
Absolute neutrophil count >= 1,500/mm^3
-
Hemoglobin >= 9 g/dL
-
Platelets >= 100,000/mm^3
-
Total bilirubin <= institutional upper limit of normal (ULN) or <= 1.5 X institutional ULN (if the patient has liver metastases)
-
Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) <= 3 X institutional ULN or (<= 5 X institutional ULN if the patient has liver metastases)
-
Serum creatinine <= 1.5 X institutional ULN
-
Patient must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1
-
Patient must have life expectancy >= 12 weeks all females of childbearing potential must have a blood test or urine study within =< 2 weeks prior to randomization to rule out pregnancy; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:
- Has not undergone a hysterectomy or bilateral oophorectomy; or
- Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
-
Women of childbearing potential and sexually active males must be strongly advised to use an accepted and effective method of contraception or to abstain from sexual intercourse for the duration of their participation in the study; should a woman become pregnant while participating in this study, she should inform her treating physician immediately; if a man impregnates a woman while participating in this study, he should inform his treating physician immediately
-
Patient must be able to swallow pills
-
Patient must be able to tolerate CT or magnetic resonance (MR) imaging including contrast agents as required for their treatment and the protocol
Exclusion Criteria:
-
Small cell carcinoma
-
Prior temozolomide, dacarbazine (DTIC), or capecitabine, or 5-FU (fluorouracil) therapy
-
Receiving any other investigational agents while on study treatment
-
Receiving Coumadin while on treatment; other anticoagulants are allowed
-
Patients with either clinically apparent central nervous system metastases or carcinomatous meningitis are ineligible
-
Active or uncontrolled infection or serious medical or psychiatric illness
-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide or capecitabine
-
Absorption issues that would limit the ability to absorb study agents
-
Patients with a history of the following within 12 months of study entry:
- Arterial thromboembolic events
- Unstable angina
- Myocardial Infarction
-
Symptomatic peripheral vascular disease
-
Patients with previous or concurrent malignancy; exceptions are made for patients who meet any of the following conditions:
- Non-melanoma skin cancer, in situ cervical cancer, or breast cancer in situ OR
- Prior malignancy completely excised or removed and patient has been continuously disease free for > 5 years OR
- Prior malignancy cured by non-surgical modalities and patient has been continuously disease free for > 5 years
-
Pregnant or breast-feeding
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Arm A (temozolomide)
Patients receive temozolomide PO QD on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Outros nomes:
|
|
Experimental: Arm B (temozolomide and capecitabine)
Patients receive capecitabine PO BID on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Outros nomes:
Given PO
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Progression-free Survival
Prazo: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Progression-free survival (PFS) is defined as the time from randomization to progression or death without evidence of progression. Progression was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of at least 5 mm. Kaplan-Meier method was used to estimate PFS. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Proportion of Patients With Response
Prazo: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Overall Survival
Prazo: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Overall survival is defined as time from randomization to death or date last known alive. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Immunohistochemistry (IHC) and Response
Prazo: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status was determined by IHC using paraffin-embedded sections of 4µm. A score (H-score) was generated based on the findings and scoring was performed by two pathologists. This H-score ranges from 0 (no staining in the tumor) to 300 (diffuse intense staining of the tumor). The highest score was used if there was disagreement. H-scores were grouped into 3 standard categories for MGMT status: Category 1 - <=50 Category 2 - 51-100 Category 3 - >100 |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Promoter Methylation and Response
Prazo: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status is determined by promoter methylation, a clinically validated methylation-specific polymerase chain reaction (PCR) analysis. A tumor sample is considered positive for MGMT promoter methylation if an 80bp band is detected in the methylated PCR reaction. It would be considered MGMT negative if an 80bp band is not detected in the methylated PCR reaction. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Pamela Kunz, ECOG-ACRIN Cancer Research Group
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimado)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Doenças do Sistema Endócrino
- Neoplasias por local
- Neoplasias
- Neoplasias por Tipo Histológico
- Neoplasias do Aparelho Digestivo
- Doenças do aparelho digestivo
- Neoplasias das Glândulas Endócrinas
- Doenças pancreáticas
- Neoplasias Glandulares e Epiteliais
- Adenocarcinoma
- Adenoma
- Carcinoma
- Tumores Neuroectodérmicos
- Neoplasias, Células Germinativas e Embrionárias
- Tumores Neuroendócrinos
- Carcinoma Neuroendócrino
- Neoplasias Pancreáticas
- Adenoma, Célula Ilhota
- Carcinoma de Células Ilhéus
- Gastrinoma
- Insulinoma
- Glucagonoma
- Somatostatinoma
- Produtos químicos orgânicos
- Compostos heterocíclicos, 1 anel
- Compostos heterocíclicos
- Azoles
- Ácidos nucleicos, nucleotídeos e nucleosídeos
- Dacarbazina
- Triazenos
- Imidazoles
- Desoxicitidina
- Citidina
- Nucleosídeos de pirimidina
- Pirimidinas
- Nucleosídeos
- Uracil
- Pirimidinonas
- Desoxirribonucleosídeos
- Fluorouracil
- Temozolomida
- Capecitabina
Outros números de identificação do estudo
- E2211
- U10CA180820 (Concessão/Contrato do NIH dos EUA)
- U10CA021115 (Concessão/Contrato do NIH dos EUA)
- E2211 (Outro identificador: ECOG-ACRIN Cancer Research Group)
- NCI-2012-02007 (Identificador de registro: CTRP (Clinical Trial Reporting Program))
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .